172
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent

Pages 1067-1073 | Published online: 12 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jeffrey J Tomaszewski & Marc C Smaldone. (2010) Emerging intravesical therapies for management of nonmuscle invasive bladder cancer. Open Access Journal of Urology 2, pages 67-84.
Read now
Marc C Smaldone, Daniel P Casella, Daniel R Welchons & Jeffrey R Gingrich. (2010) Investigational therapies for non-muscle invasive bladder cancer. Expert Opinion on Investigational Drugs 19:3, pages 371-383.
Read now

Articles from other publishers (13)

Solmaz Ohadian Moghadam & Mohammad Reza Nowroozi. (2019) Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy. Scandinavian Journal of Immunology 90:6.
Crossref
Jin-Feng Zhong, Wei-Gao Wu, Aseyinjan Tastan, Xiao-Qing Zhang, Bin Wang, Xiao-Peng Tang & Re-Jun Fang. (2018) Effects of an immune stimulant, inactivated Mycobacterium phlei, on the growth performance as well as meat quality of fattening pigs . Animal Science Journal 89:4, pages 703-712.
Crossref
C Mario Filion, Lucas Rodrigues, Chad Johannes & Aleksandar Masic. (2017) The in Vitro and in Vivo Anti-Cancer Potential of Mycobacterium Cell Wall Fraction (MCWF) Against Canine Transitional Cell Carcinoma of the Urinary Bladder. Acta Veterinaria 67:4, pages 477-494.
Crossref
Philip L. Ho, Stephen B. Williams & Ashish M. Kamat. (2015) Immune Therapies in Non-Muscle Invasive Bladder Cancer. Current Treatment Options in Oncology 16:2.
Crossref
Dong Zhang, Peng Sun, Peng Li, Aibing Xue, Xiaokai Zhang, Haiyang Zhang & Xunbo Jin. (2013) A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials 34:38, pages 10258-10266.
Crossref
Hélène LaRue, Cherifa Ayari, Alain Bergeron & Yves Fradet. (2013) Toll-like receptors in urothelial cells—targets for cancer immunotherapy. Nature Reviews Urology 10:9, pages 537-545.
Crossref
Erik L. Brincks, Michael C. Risk & Thomas S. Griffith. (2013) PMN and anti-tumor immunity—The case of bladder cancer immunotherapy. Seminars in Cancer Biology 23:3, pages 183-189.
Crossref
Cristian Speil & Robert Rzepka. (2011) Vaccines and Vaccine Adjuvants as Biological Response Modifiers. Infectious Disease Clinics of North America 25:4, pages 755-772.
Crossref
Timothy P. Kresowik & Thomas S. Griffith. 2010. Emerging Cancer Therapy. Emerging Cancer Therapy 49 70 .
Edmund Chiong & Kesavan Esuvaranathan. (2009) New therapies for non-muscle-invasive bladder cancer. World Journal of Urology 28:1, pages 71-78.
Crossref
J. Alfred Witjes, Kees Hendricksen, O. Gofrit, O. Risi & O. Nativ. (2009) Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo® working party. World Journal of Urology 27:3, pages 319-324.
Crossref
Timothy P KresowikThomas S Griffith. (2009) Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy 1:2, pages 281-288.
Crossref
R. Bartoletti & T. Cai. (2018) Endocavitary Prophylaxis of Superficial Urothelial Bladder Tumours: New Compounds. Urologia Journal 76:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.